Late-onset neutropenia following rituximab results from a hematopoietic lineage competition due to an excessive BAFF-induced B-cell recovery.
about
Late-onset neutropenia after treatment with rituximab for rheumatoid arthritis and other autoimmune diseases: data from the AutoImmunity and Rituximab registry.Late-onset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro)myelocyte stage of granulopoiesis.Immunoglobulin G Fc receptor FcgammaRIIIa 158 V/F polymorphism correlates with rituximab-induced neutropenia after autologous transplantation in patients with non-Hodgkin's lymphoma.Late-onset neutropenia following rituximab therapy in rheumatic diseases: association with B lymphocyte depletion and infections.Late-onset neutropenia following rituximab therapy: incidence, clinical features and possible mechanisms.Rituximab associated neutropenia: description of three cases and an insight into the underlying pathogenesisDynamics of B-Cell Populations in CSF and Blood in Patients Treated with a Combination of Rituximab and Mitoxantrone.Anti-CD137 enhances anti-CD20 therapy of systemic B-cell lymphoma with altered immune homeostasis but negligible toxicity.The late adverse events of rituximab therapy--rare but there!Development of autoimmunity in lymphoma.Unexpected hematologic effects of biotherapeutics in nonclinical species and in humans.Preliminary analysis of mortality associated with rituximab use in autoimmune diseases.Description of late onset neutropenia in indolent lymphoma patients treated with bendamustine plus rituximab.GM-CSF and IL-4 Fusion Cytokine Induces B Cell-Dependent Hematopoietic Regeneration.Late-onset neutropenia after rituximab in ANCA-associated vasculitis.Adverse events to monoclonal antibodies used for cancer therapy: Focus on hypersensitivity responses.Impact of rituximab on stem cell mobilization following ACVBP regimen in poor-risk patients with diffuse large B-cell lymphoma: results from a large cohort of patients.Pathway-Based Analysis of Genome-Wide Association Data Identified SNPs in HMMR as Biomarker for Chemotherapy- Induced Neutropenia in Breast Cancer Patients.
P2860
Q31012265-DE385700-2EF9-4881-B940-0DEA6511A607Q33320029-6465B1E6-F793-48FD-8CB4-2795D41F81B2Q33627797-5B558679-4138-45B1-ADF9-E8943C79140FQ33895391-DEAD7BEE-D93B-4832-AE2D-7C1A99863DEAQ34072947-7D02E4F7-F288-4467-96D4-F25BBDDED89AQ36516345-7BE3DF44-813A-4DAD-AE0F-D14FA7AA5EDBQ37200093-9A2C964E-1A10-48AD-9AE1-7F77ED8C5E54Q37222143-D2050654-43BD-4F51-A429-F13661E81340Q37462485-35A40A85-8523-44D7-9A3B-9CBB05B582ECQ37754707-142AE53B-7FBB-43FC-879B-D3F1A4749C45Q38087506-F0DF7BA0-51D8-4EB8-AB5A-8A565F557F36Q38154934-833CB3D7-4BD9-45BE-A180-FE48D3252D2BQ38689784-C76F107E-9E41-4045-B2A6-771D6BB83E4AQ38983623-6CB68FAE-97C6-41FB-A477-A6B6E81D96BBQ39944154-D5356020-C1BE-41F5-980A-1AA2760F9D57Q42908395-606BE988-BD03-497C-A4FC-B5FF8429E277Q44233582-F0B055F3-8B3B-400A-BC1E-0048197C1148Q52723445-A84A0129-BD94-4BF2-B27D-6BD1B4D4C1BE
P2860
Late-onset neutropenia following rituximab results from a hematopoietic lineage competition due to an excessive BAFF-induced B-cell recovery.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Late-onset neutropenia followi ...... BAFF-induced B-cell recovery.
@en
Late-onset neutropenia followi ...... BAFF-induced B-cell recovery.
@nl
type
label
Late-onset neutropenia followi ...... BAFF-induced B-cell recovery.
@en
Late-onset neutropenia followi ...... BAFF-induced B-cell recovery.
@nl
prefLabel
Late-onset neutropenia followi ...... BAFF-induced B-cell recovery.
@en
Late-onset neutropenia followi ...... BAFF-induced B-cell recovery.
@nl
P2093
P356
P1433
P1476
Late-onset neutropenia followi ...... BAFF-induced B-cell recovery.
@en
P2093
Agnès Buzyn
Aurélie Hummel
Benjamin Terrier
Fawzia Louache
Frédéric Lavie
Léa Tourneur
Marc Ittah
Nicole Casadevall
Sophie Candon
Vassili Soumelis
P356
10.3324/HAEMATOL.11031
P577
2007-02-01T00:00:00Z